Hologic (HOLX) Financials

$58.29 +0.14 (+0.24%)

As of 04/24/2025 04:00 PM Eastern

Annual Income Statements for Hologic

This table shows Hologic's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	132	331	-	-111	-204	1,115	1,872	1,302	456	790
Consolidated Net Income / (Loss)	132	331	756	-111	-204	1,111	1,870	1,302	456	790
Net Income / (Loss) Continuing Operations	132	331	-	-111	-204	1,111	1,870	1,302	456	790
Total Pre-Tax Income	177	415	1,231	-419	-258	1,002	2,361	1,588	676	865
Total Operating Income	455	549	1,370	-238	-124	1,105	2,480	1,640	668	883
Total Gross Profit	1,433	1,563	-	1,697	1,171	2,228	3,796	2,997	2,072	2,228
Total Revenue	2,705	2,833	-	3,218	3,367	3,776	5,632	4,863	4,030	4,030
Operating Revenue	2,705	2,833	3,059	3,218	3,367	3,776	5,632	4,863	4,030	4,030
Total Cost of Revenue	1,272	1,066	-	1,521	2,196	1,549	1,837	1,865	1,959	1,803
Operating Cost of Revenue	1,272	1,066	1,203	1,521	2,196	1,549	1,837	1,865	1,959	1,803
Total Operating Expenses	978	1,218	-	1,935	1,295	1,123	1,316	1,357	1,403	1,345
Selling, General & Admin Expense	261	267	343	366	332	356	433	408	392	409
Marketing Expense	363	415	499	545	565	485	561	630	595	585
Research & Development Expense	215	232	233	219	232	223	276	283	294	273
Amortization Expense	110	293	297	59	52	40	42	45	28	29
Other Operating Expenses / (Income)	-	-	-	-	0.00	0.30	-6.70	-40	-15	1.70
Impairment Charge	-	0.00	0.00	732	107	4.40	0.00	28	44	5.60
Restructuring Charge	29	11	13	14	6.60	15	9.30	2.40	12	41
Other Special Charges / (Income)	0.00	0.00	-900	-	-	-	0.00	0.00	52	0.00
Total Other Income / (Expense), net	-278	-133	-	-181	-134	-103	-119	-52	7.70	-18
Interest Expense	268	161	156	195	142	117	115	96	111	122
Interest & Investment Income	1.30	0.70	3.80	6.30	4.60	4.30	1.40	13	121	109
Other Income / (Expense), net	-11	27	13	7.60	3.10	9.10	-5.40	31	-1.70	-4.10
Income Tax Expense	46	85	475	-307	-54	-109	491	286	220	76
Basic Earnings per Share	$0.47	$1.18	$2.70	($0.40)	($0.76)	$4.24	$7.28	$5.18	$1.85	$3.35
Weighted Average Basic Shares Outstanding	280.57M	280.21M	559.62M	275.11M	269.41M	262.73M	257.05M	251.53M	246.77M	235.72M
Diluted Earnings per Share	$0.45	$1.16	$2.64	($0.40)	($0.76)	$4.21	$7.21	$5.13	$1.83	$3.32
Weighted Average Diluted Shares Outstanding	289.54M	286.16M	565.46M	275.11M	269.41M	264.61M	259.71M	253.85M	248.83M	237.55M
Weighted Average Basic & Diluted Shares Outstanding	280M	280.30M	279.81M	289.21M	268.15M	257.01M	251.42M	245.83M	240.00M	226.94M

This table shows Hologic's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Net Income / (Loss) Attributable to Common Shareholders	228	119	187	219	-41	91	247	170	195	179	201
Consolidated Net Income / (Loss)	228	119	187	219	-41	91	247	170	195	179	201
Net Income / (Loss) Continuing Operations	228	119	187	219	-41	91	247	170	195	179	201
Total Pre-Tax Income	248	144	239	279	12	146	191	212	241	222	248
Total Operating Income	264	141	262	272	1.40	133	198	210	244	230	230
Total Gross Profit	550	515	618	586	368	500	568	542	560	558	581
Total Revenue	1,003	953	1,074	1,027	984	945	1,013	1,018	1,011	988	1,022
Operating Revenue	1,003	953	1,074	1,027	984	945	1,013	1,018	1,011	988	1,022
Total Cost of Revenue	453	439	456	441	617	445	446	476	451	430	441
Operating Cost of Revenue	453	439	456	441	617	445	446	476	451	430	441
Total Operating Expenses	286	374	356	314	366	368	369	332	316	328	351
Selling, General & Admin Expense	92	97	109	101	90	93	112	100	94	103	116
Marketing Expense	152	159	164	142	150	140	149	144	146	146	166
Research & Development Expense	65	76	75	74	73	73	67	75	64	67	60
Amortization Expense	11	12	7.60	7.10	7.10	6.30	13	5.70	5.30	4.90	4.70
Other Operating Expenses / (Income)	-35	-	0.00	-12	-	-	1.70	0.00	-	-	0.00
Impairment Charge	0.00	-	0.00	0.00	44	-	4.30	0.90	0.40	-	0.00
Restructuring Charge	0.80	1.60	1.10	1.80	2.10	7.00	23	6.10	6.20	6.30	3.90
Total Other Income / (Expense), net	-16	2.60	-23	7.20	11	13	-6.90	1.10	-3.30	-8.40	18
Interest Expense	23	24	28	27	28	28	26	32	32	32	31
Interest & Investment Income	2.40	9.20	21	32	33	36	28	24	28	28	24
Other Income / (Expense), net	4.80	18	-16	2.90	5.90	5.30	-8.80	9.40	0.20	-4.90	24
Income Tax Expense	20	25	52	61	53	55	-55	42	46	43	47
Basic Earnings per Share	$0.91	$0.49	$0.76	$0.88	($0.16)	$0.37	$1.03	$0.72	$0.83	$0.77	$0.87
Weighted Average Basic Shares Outstanding	250.76M	251.53M	247.32M	247.73M	246.91M	246.77M	238.63M	235.89M	234.60M	235.72M	230.28M
Diluted Earnings per Share	$0.90	$0.48	$0.75	$0.87	($0.16)	$0.37	$1.03	$0.72	$0.82	$0.75	$0.87
Weighted Average Diluted Shares Outstanding	253.09M	253.85M	249.28M	249.79M	246.91M	248.83M	240.21M	237.56M	236.47M	237.55M	232.11M
Weighted Average Basic & Diluted Shares Outstanding	249.65M	245.83M	246.55M	246.12M	244.94M	240.00M	234.73M	233.38M	232.27M	226.94M	224.39M

This table details how cash moves in and out of Hologic's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-245	57	-7.80	133	-65	99	469	1,169	416	-596
Net Cash From Operating Activities	797	798	8.30	733	650	897	2,330	2,126	1,051	1,285
Net Cash From Continuing Operating Activities	797	798	8.30	733	650	897	2,330	2,126	1,051	1,285
Net Income / (Loss) Continuing Operations	132	331	756	-111	-204	1,111	1,870	1,302	456	790
Consolidated Net Income / (Loss)	132	331	756	-111	-204	1,111	1,870	1,302	456	790
Depreciation Expense	82	82	90	102	93	83	88	89	90	99
Amortization Expense	474	435	409	379	371	293	319	341	234	210
Non-Cash Adjustments To Reconcile Net Income	160	49	-785	867	782	141	118	145	384	173
Changes in Operating Assets and Liabilities, net	-50	-99	-460	-504	-392	-730	-64	249	-112	14
Net Cash From Investing Activities	-86	-68	286	-195	-281	-142	-1,330	-206	-152	-781
Net Cash From Continuing Investing Activities	-86	-68	286	-195	-281	-142	-1,330	-206	-152	-781
Purchase of Property, Plant & Equipment	-89	-95	-108	-106	-109	-156	-178	-127	-150	-130
Acquisitions	0.00	0.00	-1,558	-77	-133	-119	-1,171	-159	-5.00	-307
Purchase of Investments	-	0.00	0.00	-6.00	-	-	-	0.00	-10	-310
Divestitures	0.00	0.00	1,865	0.00	0.00	139	-	0.00	0.00	-31
Other Investing Activities, net	-6.70	-10	-0.60	-7.10	-38	-5.10	19	80	13	-2.00
Net Cash From Financing Activities	-947	-671	-309	-405	-432	-660	-530	-756	-483	-1,109
Net Cash From Continuing Financing Activities	-947	-671	-309	-405	-432	-660	-530	-756	-483	-1,109
Repayment of Debt	-3,844	-693	-530	-4,176	-2,279	-796	-431	-1,700	-15	-288
Repurchase of Common Equity	0.00	-250	-200	-276	-200	-654	-410	-542	-475	-835
Issuance of Common Equity	70	39	49	33	50	66	51	34	43	38
Other Financing Activities, net	-26	-16	-22	-20	-23	-40	-52	-39	-36	-24
Effect of Exchange Rate Changes	-8.10	-2.00	7.30	-	-	4.10	-1.70	-	-	8.90

This table details how cash moves in and out of Hologic's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Net Change in Cash & Equivalents	85	-36	102	141	183	-9.30	-824	248	259	-279	-378
Net Cash From Operating Activities	331	169	253	206	333	259	220	292	406	367	189
Net Cash From Continuing Operating Activities	331	169	253	206	333	259	220	292	406	367	189
Net Income / (Loss) Continuing Operations	228	119	187	219	-41	91	247	170	195	179	201
Consolidated Net Income / (Loss)	228	119	187	219	-41	91	247	170	195	179	201
Depreciation Expense	22	22	23	22	22	23	30	23	23	24	23
Amortization Expense	87	85	63	59	59	53	59	51	50	51	51
Non-Cash Adjustments To Reconcile Net Income	38	47	50	24	242	69	61	48	38	27	11
Changes in Operating Assets and Liabilities, net	-45	-104	-70	-117	50	24	-175	0.70	101	87	-97
Net Cash From Investing Activities	-9.80	-32	-41	-16	-39	-56	-104	-39	-43	-596	-22
Net Cash From Continuing Investing Activities	-9.80	-32	-41	-16	-39	-56	-104	-39	-43	-596	-22
Purchase of Property, Plant & Equipment	-26	-32	-29	-32	-37	-53	-38	-28	-34	-30	-32
Acquisitions	-0.20	-	-10	-	-	-5.00	0.00	-	-	-297	-16
Purchase of Investments	-	-	-	-	-	-	-35	-	-3.00	-268	-6.00
Divestitures	-	-	0.00	-	-	-	-31	-	-	-	0.00
Sale and/or Maturity of Investments	-	-	-	-	-	-	0.00	-	-	-	32
Other Investing Activities, net	16	-0.50	-1.90	16	-2.20	1.50	-0.40	-5.50	4.30	-0.40	-0.70
Net Cash From Financing Activities	-240	-170	-114	-50	-110	-211	-944	-4.20	-104	-57	-537
Net Cash From Continuing Financing Activities	-240	-170	-114	-50	-110	-211	-944	-4.20	-104	-57	-537
Repayment of Debt	-1,740	-	-3.80	-3.70	-3.80	-3.70	-259	-9.40	-9.30	-9.40	-9.40
Repurchase of Common Equity	-	-175	-100	-50	-114	-211	-677	-	-100	-58	-517
Issuance of Common Equity	9.60	6.60	15	13	9.30	5.30	9.50	8.90	6.80	13	12
Other Financing Activities, net	-1.20	-1.30	-25	-9.10	-1.50	-1.00	-17	-3.70	-1.30	-1.70	-23
Effect of Exchange Rate Changes	-	-	2.90	0.50	-1.70	-	4.40	-1.80	-0.30	6.60	-8.40

This table presents Hologic's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	7,643	7,317	7,980	7,231	6,442	7,196	8,920	9,071	9,139	9,156
Total Current Assets	1,266	1,327	1,479	1,723	1,793	2,222	3,169	3,862	4,185	3,823
Cash & Equivalents	491	548	541	667	602	701	0.00	0.00	2,723	2,160
Short-Term Investments	-	-	-	-	-	-	-	-	0.00	173
Accounts Receivable	416	447	534	579	649	1,029	943	618	626	600
Inventories, net	283	275	332	384	445	395	501	624	618	680
Prepaid Expenses	33	40	51	62	63	59	529	232	175	156
Current Deferred & Refundable Income Taxes	41	17	22	32	35	39	26	49	32	53
Plant, Property, & Equipment, net	457	460	473	478	471	492	565	482	517	538
Total Noncurrent Assets	5,920	5,530	6,028	5,030	4,178	4,482	5,187	4,728	4,438	4,795
Long-Term Investments	-	-	-	-	-	-	-	-	0.00	96
Goodwill	2,808	2,803	3,171	2,533	2,564	2,658	3,282	3,237	3,281	3,443
Intangible Assets	3,023	2,643	2,772	2,399	1,460	1,308	1,659	1,281	889	845
Other Noncurrent Operating Assets	88	84	85	98	155	517	246	211	268	411
Total Liabilities & Shareholders' Equity	7,643	7,317	7,980	7,231	6,442	7,196	8,920	9,071	9,139	9,156
Total Liabilities	5,563	5,174	5,195	4,802	4,326	4,489	4,701	4,195	4,122	4,026
Total Current Liabilities	943	902	1,866	1,403	1,070	1,239	1,327	938	1,207	1,037
Short-Term Debt	391	296	1,152	601	273	325	313	15	287	38
Accounts Payable	117	157	167	192	187	179	216	198	175	204
Accrued Expenses	272	288	375	436	431	548	596	535	535	580
Current Deferred Revenue	163	161	171	173	180	186	198	187	199	213
Other Current Liabilities	-	-	-	-	-	1.90	3.70	3.20	3.10	3.30
Total Noncurrent Liabilities	4,620	4,272	3,329	3,400	3,256	3,249	3,375	3,257	2,915	2,989
Long-Term Debt	3,221	3,049	2,172	2,705	2,784	2,714	2,712	2,808	2,531	2,497
Capital Lease Obligations	-	0.00	23	21	19	-	23	18	15	12
Noncurrent Deferred Revenue	20	16	21	18	16	13	20	9.40	14	14
Noncurrent Deferred & Payable Income Tax Liabilities	1,178	983	974	498	275	202	251	91	20	59
Other Noncurrent Operating Liabilities	201	225	140	158	162	321	369	331	335	406
Total Equity & Noncontrolling Interests	2,079	2,143	2,785	2,429	2,116	2,707	4,219	4,876	5,017	5,130
Total Preferred & Common Equity	2,079	2,143	2,785	2,429	2,116	2,705	4,219	4,876	5,017	5,130
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,079	2,143	2,785	2,429	2,116	2,705	4,219	4,876	5,017	5,130
Common Stock	5,563	5,563	5,634	5,674	5,773	5,908	5,969	6,046	6,144	6,247
Retained Earnings	-3,469	-3,138	-2,383	-2,494	-2,689	-1,573	298	1,600	2,056	2,846
Treasury Stock	0.00	-250	-450	-726	-926	-1,580	-1,989	-2,532	-3,036	-3,852
Accumulated Other Comprehensive Income / (Loss)	-15	-32	-16	-26	-42	-50	-59	-238	-148	-112

This table presents Hologic's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Total Assets	9,357	9,071	9,290	9,449	9,338	9,139	8,470	8,714	8,890	9,156	8,729
Total Current Assets	3,909	3,862	4,021	4,211	4,339	4,185	3,494	3,789	3,997	3,823	3,494
Cash & Equivalents	2,375	0.00	2,441	2,582	2,765	2,723	1,932	2,180	2,439	2,160	1,782
Short-Term Investments	-	-	-	-	-	0.00	-	-	-	173	191
Accounts Receivable	703	618	674	714	687	626	671	647	629	600	631
Inventories, net	581	624	678	688	680	618	634	649	666	680	707
Prepaid Expenses	250	232	228	228	207	175	258	312	158	156	158
Current Deferred & Refundable Income Taxes	-	49	-	-	-	32	-	-	106	53	24
Plant, Property, & Equipment, net	490	482	494	498	493	517	527	525	529	538	537
Total Noncurrent Assets	4,958	4,728	4,775	4,739	4,505	4,438	4,448	4,401	4,364	4,795	4,698
Long-Term Investments	-	-	-	-	-	0.00	-	-	-	96	48
Goodwill	3,286	3,237	3,290	3,297	3,298	3,281	3,306	3,292	3,291	3,443	3,423
Intangible Assets	1,437	1,281	1,255	1,202	940	889	833	752	688	845	793
Other Noncurrent Operating Assets	236	211	230	240	267	268	310	357	386	411	434
Total Liabilities & Shareholders' Equity	9,357	9,071	9,290	9,449	9,338	9,139	8,470	8,714	8,890	9,156	8,729
Total Liabilities	4,360	4,195	4,198	4,148	4,156	4,122	3,816	3,870	3,939	4,026	3,955
Total Current Liabilities	1,001	938	956	955	981	1,207	899	955	1,002	1,037	1,002
Short-Term Debt	7.50	15	21	26	32	287	37	37	38	38	47
Accounts Payable	217	198	202	187	181	175	184	203	202	204	237
Accrued Expenses	574	535	539	508	533	535	484	504	541	580	528
Current Deferred Revenue	200	187	192	231	233	199	191	208	219	213	188
Other Current Liabilities	3.50	3.20	3.20	2.90	2.90	3.10	3.20	3.20	3.20	3.30	3.30
Total Noncurrent Liabilities	3,359	3,257	3,242	3,193	3,175	2,915	2,917	2,915	2,937	2,989	2,953
Long-Term Debt	2,815	2,808	2,806	2,798	2,789	2,531	2,523	2,514	2,506	2,497	2,479
Capital Lease Obligations	19	18	18	17	16	15	15	14	13	12	11
Noncurrent Deferred Revenue	11	9.40	11	13	14	14	14	15	15	14	12
Noncurrent Deferred & Payable Income Tax Liabilities	208	91	72	33	19	20	20	18	18	59	54
Other Noncurrent Operating Liabilities	306	331	335	332	336	335	345	354	386	406	397
Total Equity & Noncontrolling Interests	4,998	4,876	5,093	5,301	5,182	5,017	4,654	4,844	4,951	5,130	4,773
Total Preferred & Common Equity	4,998	4,876	5,093	5,301	5,182	5,017	4,654	4,844	4,951	5,130	4,773
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,998	4,876	5,093	5,301	5,182	5,017	4,654	4,844	4,951	5,130	4,773
Common Stock	6,020	6,046	6,064	6,095	6,126	6,144	6,062	6,201	6,216	6,247	6,262
Retained Earnings	1,482	1,600	1,788	2,006	1,966	2,056	2,303	2,473	2,667	2,846	3,047
Treasury Stock	-2,356	-2,532	-2,632	-2,682	-2,796	-3,036	-3,592	-3,692	-3,793	-3,852	-4,373
Accumulated Other Comprehensive Income / (Loss)	-148	-238	-127	-118	-114	-148	-119	-137	-140	-112	-163

This table displays calculated financial ratios and metrics derived from Hologic's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.89%	4.72%	7.98%	0.00%	4.64%	12.15%	49.14%	-13.66%	-17.12%	0.00%
EBITDA Growth	15.30%	9.35%	72.21%	-86.71%	36.96%	335.19%	93.40%	-27.09%	-52.88%	19.94%
EBIT Growth	61.61%	29.52%	140.46%	-116.65%	47.59%	1,023.03%	122.14%	-32.48%	-60.10%	31.77%
NOPAT Growth	235.97%	29.29%	92.52%	-119.80%	47.96%	1,513.31%	60.36%	-31.54%	-66.47%	78.67%
Net Income Growth	660.69%	151.37%	128.39%	-114.73%	-82.93%	645.43%	68.37%	-30.36%	-64.98%	73.14%
EPS Growth	650.00%	157.78%	127.59%	-115.15%	-90.00%	653.95%	71.26%	-28.85%	-64.33%	81.42%
Operating Cash Flow Growth	56.73%	0.18%	-98.96%	8,730.12%	-11.38%	38.04%	159.92%	-8.78%	-50.55%	22.26%
Free Cash Flow Firm Growth	70.78%	-4.45%	-72.75%	77.03%	22.83%	86.59%	18.62%	125.97%	-66.41%	0.28%
Invested Capital Growth	-6.99%	-4.98%	13.19%	-8.98%	-9.81%	9.92%	20.84%	-11.78%	-4.50%	2.16%
Revenue Q/Q Growth	1.58%	0.85%	2.55%	0.00%	1.58%	14.60%	-0.54%	-6.95%	-0.20%	1.07%
EBITDA Q/Q Growth	1.25%	2.17%	-1.80%	-10.68%	-35.13%	91.46%	-6.04%	-11.97%	-4.96%	7.85%
EBIT Q/Q Growth	5.61%	5.87%	-2.65%	-2.17%	-267.41%	190.74%	-7.78%	-14.11%	-3.00%	11.03%
NOPAT Q/Q Growth	13.51%	4.68%	-1.12%	-4.53%	-300.65%	68.61%	-7.29%	-14.90%	-7.26%	15.41%
Net Income Q/Q Growth	-2.16%	25.40%	-1.24%	-40.71%	-587.84%	125.03%	-8.10%	-13.89%	-5.80%	12.54%
EPS Q/Q Growth	-4.26%	27.47%	-1.49%	-29.03%	-660.00%	126.34%	-7.68%	-13.64%	-5.67%	12.93%
Operating Cash Flow Q/Q Growth	16.27%	-1.81%	-88.18%	9.86%	2.41%	27.67%	1.01%	-12.25%	9.37%	9.20%
Free Cash Flow Firm Q/Q Growth	8.62%	1.66%	-46.01%	53.12%	27.34%	1.38%	20.34%	-10.59%	-0.37%	-21.45%
Invested Capital Q/Q Growth	-1.74%	-1.67%	1.24%	-1.08%	-5.63%	4.43%	-1.53%	-1.56%	-2.25%	3.53%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	52.96%	55.19%	52.99%	52.73%	34.77%	58.98%	67.39%	61.64%	51.40%	55.28%
EBITDA Margin	36.94%	38.57%	61.52%	7.77%	10.17%	39.46%	51.17%	43.21%	24.57%	29.46%
Operating Margin	16.82%	19.37%	44.80%	-7.39%	-3.68%	29.26%	44.04%	33.73%	16.58%	21.90%
EBIT Margin	16.42%	20.31%	45.22%	-7.16%	-3.58%	29.50%	43.94%	34.37%	16.54%	21.80%
Profit (Net Income) Margin	4.87%	11.68%	24.70%	-3.46%	-6.05%	29.41%	33.20%	26.77%	11.31%	19.59%
Tax Burden Percent	74.27%	79.65%	61.40%	26.59%	79.01%	110.84%	79.19%	81.98%	67.45%	91.26%
Interest Burden Percent	39.90%	72.20%	88.97%	181.76%	213.50%	89.93%	95.40%	95.04%	101.41%	98.47%
Effective Tax Rate	25.73%	20.35%	38.60%	0.00%	0.00%	-10.84%	20.81%	18.02%	32.55%	8.74%
Return on Invested Capital (ROIC)	6.27%	8.62%	15.98%	-3.12%	-1.79%	25.42%	35.26%	23.44%	8.58%	15.52%
ROIC Less NNEP Spread (ROIC-NNEP)	0.05%	5.03%	12.92%	-1.10%	-6.35%	20.67%	30.78%	19.85%	10.25%	1.98%
Return on Net Nonoperating Assets (RNNOA)	0.09%	7.05%	14.69%	-1.15%	-7.17%	20.63%	18.73%	5.19%	0.64%	0.05%
Return on Equity (ROE)	6.35%	15.67%	30.67%	-4.27%	-8.96%	46.05%	53.99%	28.63%	9.22%	15.56%
Cash Return on Invested Capital (CROIC)	13.50%	13.73%	3.60%	6.29%	8.52%	15.97%	16.39%	35.96%	13.18%	13.38%
Operating Return on Assets (OROA)	5.53%	7.69%	18.08%	-3.03%	-1.77%	16.34%	30.71%	18.58%	7.32%	9.60%
Return on Assets (ROA)	1.64%	4.42%	9.88%	-1.46%	-2.98%	16.29%	23.20%	14.47%	5.01%	8.63%
Return on Common Equity (ROCE)	6.35%	15.67%	30.67%	-4.27%	-8.96%	46.03%	53.98%	28.63%	9.22%	15.56%
Return on Equity Simple (ROE_SIMPLE)	6.33%	15.44%	27.13%	-4.58%	-9.62%	41.05%	44.32%	26.70%	9.09%	15.39%
Net Operating Profit after Tax (NOPAT)	338	437	841	-167	-87	1,225	1,964	1,345	451	805
NOPAT Margin	12.49%	15.43%	27.50%	-5.18%	-2.57%	32.43%	34.87%	27.65%	11.19%	19.99%
Net Nonoperating Expense Percent (NNEP)	6.21%	3.59%	3.06%	-2.02%	4.56%	4.75%	4.48%	3.58%	-1.67%	13.53%
Cost of Revenue to Revenue	47.04%	37.62%	47.01%	47.27%	65.23%	41.02%	32.61%	38.36%	48.60%	44.72%
SG&A Expenses to Revenue	9.65%	9.44%	11.22%	11.38%	9.87%	9.42%	7.69%	8.38%	9.74%	10.16%
R&D to Revenue	7.94%	8.19%	7.61%	6.80%	6.90%	5.89%	4.91%	5.83%	7.30%	6.77%
Operating Expenses to Revenue	36.14%	43.01%	8.20%	60.12%	38.45%	29.72%	23.36%	27.91%	34.81%	33.38%
Earnings before Interest and Taxes (EBIT)	444	575	1,383	-230	-121	1,114	2,475	1,671	667	879
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	999	1,093	1,882	250	342	1,490	2,882	2,101	990	1,188
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.42	4.98	3.76	4.59	6.27	6.16	4.60	3.22	3.39	3.66
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	43.78	20.07	22.29
Price to Revenue (P/Rev)	4.17	3.77	3.43	3.47	3.94	4.41	3.44	3.23	4.22	4.66
Price to Earnings (P/E)	85.65	32.25	13.87	0.00	0.00	14.94	10.36	12.08	37.28	23.78
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.17%	3.10%	7.21%	0.00%	0.00%	6.69%	9.65%	8.28%	2.68%	4.21%
Enterprise Value to Invested Capital (EV/IC)	2.77	2.73	2.38	2.71	3.43	3.77	3.68	3.45	3.33	3.60
Enterprise Value to Revenue (EV/Rev)	5.32	4.75	4.34	4.29	4.67	5.03	3.98	3.82	4.25	4.69
Enterprise Value to EBITDA (EV/EBITDA)	14.40	12.32	7.06	55.25	45.96	12.75	7.79	8.84	17.28	15.91
Enterprise Value to EBIT (EV/EBIT)	32.41	23.41	9.61	0.00	0.00	17.06	9.06	11.11	25.66	21.50
Enterprise Value to NOPAT (EV/NOPAT)	42.58	30.81	15.79	0.00	0.00	15.52	11.42	13.81	37.95	23.45
Enterprise Value to Operating Cash Flow (EV/OCF)	18.06	16.87	1,600.87	18.85	24.23	21.20	9.63	8.73	16.28	14.70
Enterprise Value to Free Cash Flow (EV/FCFF)	19.76	19.35	70.05	41.13	38.15	24.70	24.58	9.00	24.70	27.19
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.74	1.56	1.20	1.37	1.45	1.12	0.72	0.58	0.56	0.50
Long-Term Debt to Equity	1.55	1.42	0.79	1.12	1.32	1.00	0.65	0.58	0.51	0.49
Financial Leverage	1.60	1.40	1.14	1.05	1.13	1.00	0.61	0.26	0.06	0.02
Leverage Ratio	3.88	3.54	3.10	2.92	3.01	2.83	2.33	1.98	1.84	1.80
Compound Leverage Factor	1.55	2.56	2.76	5.30	6.42	2.54	2.22	1.88	1.87	1.78
Debt to Total Capital	63.47%	60.96%	54.59%	57.80%	59.25%	52.88%	41.95%	36.82%	36.09%	33.18%
Short-Term Debt to Total Capital	6.87%	5.39%	18.79%	10.45%	5.26%	5.65%	4.31%	0.19%	3.66%	0.49%
Long-Term Debt to Total Capital	56.59%	55.56%	35.79%	47.35%	53.99%	47.23%	37.64%	36.62%	32.44%	32.69%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	36.53%	39.04%	45.41%	42.20%	40.75%	47.08%	58.05%	63.18%	63.91%	66.82%
Debt to EBITDA	3.61	3.06	1.78	13.31	8.98	2.04	1.06	1.35	2.86	2.14
Net Debt to EBITDA	3.12	2.56	1.49	10.64	7.23	1.57	1.06	1.35	0.11	0.10
Long-Term Debt to EBITDA	3.22	2.79	1.17	10.90	8.19	1.82	0.95	1.35	2.57	2.11
Debt to NOPAT	10.69	7.66	3.98	-19.98	-35.50	2.48	1.55	2.11	6.29	3.16
Net Debt to NOPAT	9.23	6.40	3.34	-15.97	-28.55	1.91	1.55	2.11	0.25	0.15
Long-Term Debt to NOPAT	9.53	6.98	2.61	-16.37	-32.34	2.22	1.39	2.10	5.65	3.12
Altman Z-Score	1.18	1.35	1.69	1.30	1.85	3.12	4.32	4.03	3.86	4.35
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.03%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.34	1.47	0.79	1.23	1.68	1.79	2.39	4.12	3.47	3.69
Quick Ratio	0.96	1.10	0.58	0.89	1.17	1.40	0.71	0.66	2.77	2.83
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	728	696	190	336	412	770	913	2,063	693	695
Operating Cash Flow to CapEx	891.28%	844.66%	7.71%	694.03%	595.33%	573.27%	1,311.42%	1,671.15%	699.87%	987.10%
Free Cash Flow to Firm to Interest Expense	2.72	4.33	1.21	1.73	2.91	6.61	7.92	21.53	6.24	5.69
Operating Cash Flow to Interest Expense	2.97	4.97	0.05	3.77	4.59	7.70	20.23	22.19	9.46	10.53
Operating Cash Flow Less CapEx to Interest Expense	2.64	4.38	-0.63	3.22	3.82	6.35	18.69	20.86	8.11	9.46
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.34	0.38	0.40	0.42	0.49	0.55	0.70	0.54	0.44	0.44
Accounts Receivable Turnover	6.66	6.56	6.24	5.78	5.48	4.50	5.71	6.23	6.48	6.57
Inventory Turnover	4.15	3.82	4.74	4.25	5.30	3.69	4.10	3.32	3.16	2.78
Fixed Asset Turnover	5.89	6.18	6.56	6.77	7.10	7.85	10.67	9.30	8.07	7.64
Accounts Payable Turnover	12.17	7.78	8.89	8.48	11.60	8.48	9.31	9.02	10.51	9.51
Days Sales Outstanding (DSO)	54.79	55.61	58.50	63.11	66.55	81.07	63.88	58.56	56.29	55.52
Days Inventory Outstanding (DIO)	88.03	95.52	76.96	85.86	68.88	98.97	89.07	110.05	115.65	131.36
Days Payable Outstanding (DPO)	29.99	46.91	41.06	43.05	31.47	43.04	39.22	40.46	34.74	38.37
Cash Conversion Cycle (CCC)	112.83	104.22	94.40	105.92	103.97	137.00	113.73	128.15	137.20	148.50
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,199	4,940	5,591	5,089	4,590	5,045	6,096	5,378	5,136	5,247
Invested Capital Turnover	0.50	0.56	0.58	0.60	0.70	0.78	1.01	0.85	0.77	0.78
Increase / (Decrease) in Invested Capital	-390	-259	652	-502	-499	455	1,051	-718	-242	111
Enterprise Value (EV)	14,392	13,464	13,287	13,812	15,735	19,006	22,435	18,565	17,110	18,889
Market Capitalization	11,272	10,667	10,481	11,152	13,261	16,666	19,387	15,723	16,999	18,772
Book Value per Share	$7.38	$7.72	$9.75	$8.93	$7.91	$10.45	$16.64	$19.53	$20.48	$22.09
Tangible Book Value per Share	($13.32)	($11.91)	($11.06)	($9.20)	($7.14)	($4.87)	($2.85)	$1.44	$3.46	$3.63
Total Capital	5,691	5,488	6,132	5,756	5,192	5,746	7,267	7,718	7,850	7,677
Total Debt	3,612	3,345	3,347	3,327	3,076	3,039	3,048	2,841	2,834	2,547
Total Long-Term Debt	3,221	3,049	2,195	2,726	2,803	2,714	2,735	2,826	2,547	2,509
Net Debt	3,120	2,797	2,807	2,660	2,474	2,338	3,048	2,841	111	117
Capital Expenditures (CapEx)	89	95	108	106	109	156	178	127	150	130
Debt-free, Cash-free Net Working Capital (DFCFNWC)	221	172	225	255	394	607	2,155	2,939	542	490
Debt-free Net Working Capital (DFNWC)	714	721	766	922	996	1,308	2,155	2,939	3,264	2,824
Net Working Capital (NWC)	322	425	-387	321	723	983	1,842	2,924	2,977	2,786
Net Nonoperating Expense (NNE)	206	106	86	-55	117	114	94	43	-5.19	16
Net Nonoperating Obligations (NNO)	3,120	2,797	2,807	2,660	2,474	2,338	1,878	502	119	117
Total Depreciation and Amortization (D&A)	555	518	499	480	463	376	407	430	323	309
Debt-free, Cash-free Net Working Capital to Revenue	8.17%	6.08%	7.35%	7.93%	11.71%	16.07%	38.26%	60.44%	13.44%	12.16%
Debt-free Net Working Capital to Revenue	26.38%	25.44%	25.03%	28.65%	29.58%	34.63%	38.26%	60.44%	80.99%	70.06%
Net Working Capital to Revenue	11.92%	14.99%	-12.65%	9.96%	21.47%	26.03%	32.70%	60.14%	73.87%	69.13%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.47	$1.18	$2.70	($0.40)	($0.76)	$4.24	$7.28	$5.18	$1.85	$3.35
Adjusted Weighted Average Basic Shares Outstanding	280.57M	280.21M	279.81M	275.11M	269.41M	262.73M	257.05M	251.53M	246.77M	235.72M
Adjusted Diluted Earnings per Share	$0.45	$1.16	$2.64	($0.40)	($0.76)	$4.21	$7.21	$5.13	$1.83	$3.32
Adjusted Weighted Average Diluted Shares Outstanding	289.54M	286.16M	285.65M	275.11M	269.41M	264.61M	259.71M	253.85M	248.83M	237.55M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	282.91M	278.22M	0.00	289.21M	268.15M	257.01M	251.42M	245.83M	240.00M	226.94M
Normalized Net Operating Profit after Tax (NOPAT)	359	445	297	356	-7.35	787	1,971	1,369	524	848
Normalized NOPAT Margin	13.28%	15.72%	9.71%	11.05%	-0.22%	20.85%	35.00%	28.16%	12.99%	21.04%
Pre Tax Income Margin	6.55%	14.66%	40.23%	-13.01%	-7.65%	26.53%	41.92%	32.66%	16.78%	21.46%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.66	3.58	8.84	-1.18	-0.85	9.56	21.48	17.44	6.00	7.19
NOPAT to Interest Expense	1.26	2.72	5.38	-0.86	-0.61	10.51	17.05	14.04	4.06	6.60
EBIT Less CapEx to Interest Expense	1.32	2.99	8.16	-1.73	-1.62	8.22	19.94	16.12	4.65	6.13
NOPAT Less CapEx to Interest Expense	0.93	2.13	4.69	-1.40	-1.38	9.17	15.51	12.71	2.71	5.53
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.16%	0.45%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	75.57%	26.49%	-247.80%	-98.28%	59.02%	22.37%	41.64%	104.12%	105.78%

This table displays calculated financial ratios and metrics derived from Hologic's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-14.17%	-27.59%	-26.98%	-28.50%	-1.83%	-0.84%	-5.69%	-0.85%	2.74%	4.52%	0.86%
EBITDA Growth	-17.77%	-51.89%	-56.01%	-49.34%	-76.59%	-19.51%	-16.45%	-17.51%	257.63%	40.51%	18.00%
EBIT Growth	-25.09%	-63.42%	-61.93%	-53.87%	-97.28%	-13.01%	-23.20%	-20.07%	3,245.21%	63.35%	34.00%
NOPAT Growth	-14.82%	-66.87%	-60.05%	-54.84%	-101.93%	-29.26%	24.18%	-20.60%	4,307.61%	124.83%	-26.93%
Net Income Growth	-14.81%	-63.90%	-62.46%	-52.05%	-117.73%	-23.67%	31.54%	-22.24%	580.25%	97.13%	-18.46%
EPS Growth	-13.46%	-62.79%	-61.54%	-51.67%	-117.78%	-22.92%	37.33%	-17.24%	612.50%	102.70%	-15.53%
Operating Cash Flow Growth	-50.11%	-63.77%	-55.09%	-80.58%	0.64%	53.44%	-13.18%	41.74%	21.94%	41.86%	-13.95%
Free Cash Flow Firm Growth	190.22%	219.35%	283.38%	-61.26%	-78.90%	-61.13%	-49.37%	103.71%	87.51%	-76.99%	-57.47%
Invested Capital Growth	-11.75%	-11.78%	-11.19%	-0.57%	-3.83%	-4.50%	-3.62%	-5.93%	-3.55%	2.16%	-0.13%
Revenue Q/Q Growth	-30.16%	-4.93%	12.68%	-4.44%	-4.10%	-3.97%	7.17%	0.46%	-0.63%	-2.31%	3.42%
EBITDA Q/Q Growth	-46.16%	-29.91%	25.47%	7.01%	-75.13%	141.02%	30.24%	5.65%	7.84%	-5.31%	9.38%
EBIT Q/Q Growth	-54.93%	-41.05%	55.68%	11.52%	-97.35%	1,787.67%	37.45%	16.05%	11.10%	-7.82%	12.75%
NOPAT Q/Q Growth	-48.52%	-51.97%	76.46%	3.50%	-102.20%	1,859.48%	209.76%	-33.82%	16.66%	-5.98%	0.68%
Net Income Q/Q Growth	-49.88%	-48.03%	57.88%	16.60%	-118.54%	323.70%	172.08%	-31.08%	14.48%	-8.17%	12.54%
EPS Q/Q Growth	-50.00%	-46.67%	56.25%	16.00%	-118.39%	331.25%	178.38%	-30.10%	13.89%	-8.54%	16.00%
Operating Cash Flow Q/Q Growth	-68.87%	-49.02%	50.30%	-18.59%	61.32%	-22.27%	-14.96%	32.91%	38.78%	-9.56%	-48.42%
Free Cash Flow Firm Q/Q Growth	53.45%	-13.93%	7.56%	-72.73%	-16.44%	58.57%	40.11%	9.73%	-23.08%	-80.54%	158.91%
Invested Capital Q/Q Growth	-2.29%	-1.56%	2.19%	1.16%	-5.49%	-2.25%	3.12%	-1.26%	-3.10%	3.53%	0.82%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	54.83%	53.99%	57.52%	57.07%	37.33%	52.93%	56.02%	53.28%	55.40%	56.45%	56.81%
EBITDA Margin	37.71%	27.80%	30.95%	34.66%	8.99%	22.56%	27.42%	28.84%	31.29%	30.33%	32.08%
Operating Margin	26.32%	14.78%	24.43%	26.51%	0.14%	14.02%	19.56%	20.67%	24.13%	23.28%	22.49%
EBIT Margin	26.80%	16.62%	22.96%	26.79%	0.74%	14.58%	18.70%	21.60%	24.14%	22.78%	24.84%
Profit (Net Income) Margin	22.78%	12.45%	17.45%	21.29%	-4.11%	9.58%	24.33%	16.69%	19.23%	18.08%	19.67%
Tax Burden Percent	91.95%	82.72%	78.38%	78.23%	-334.71%	62.23%	128.86%	80.33%	80.81%	80.60%	81.21%
Interest Burden Percent	92.45%	90.59%	96.96%	101.56%	165.75%	105.66%	101.00%	96.22%	98.57%	98.45%	97.52%
Effective Tax Rate	8.05%	17.28%	21.62%	21.77%	434.71%	37.77%	-28.86%	19.67%	19.19%	19.40%	18.79%
Return on Invested Capital (ROIC)	21.70%	10.36%	14.64%	15.09%	-0.36%	6.69%	18.54%	12.19%	15.06%	14.57%	13.94%
ROIC Less NNEP Spread (ROIC-NNEP)	20.68%	10.54%	12.87%	16.15%	-13.67%	9.31%	16.84%	12.47%	12.24%	8.83%	16.42%
Return on Net Nonoperating Assets (RNNOA)	6.48%	2.76%	2.78%	1.69%	-0.72%	0.58%	1.81%	0.79%	0.23%	0.21%	2.02%
Return on Equity (ROE)	28.18%	13.12%	17.41%	16.78%	-1.08%	7.27%	20.35%	12.98%	15.29%	14.77%	15.96%
Cash Return on Invested Capital (CROIC)	39.59%	35.96%	29.59%	14.51%	12.98%	13.18%	12.87%	14.48%	17.14%	13.38%	14.07%
Operating Return on Assets (OROA)	15.61%	8.98%	11.04%	11.46%	0.32%	6.45%	8.36%	9.42%	10.56%	10.04%	11.67%
Return on Assets (ROA)	13.27%	6.73%	8.39%	9.11%	-1.78%	4.24%	10.88%	7.28%	8.41%	7.96%	9.24%
Return on Common Equity (ROCE)	28.18%	13.12%	17.41%	16.78%	-1.08%	7.27%	20.35%	12.98%	15.29%	14.77%	15.96%
Return on Equity Simple (ROE_SIMPLE)	30.25%	0.00%	19.44%	14.21%	9.34%	0.00%	11.07%	9.63%	14.17%	0.00%	15.59%
Net Operating Profit after Tax (NOPAT)	243	117	206	213	-4.69	82	255	169	197	185	187
NOPAT Margin	24.20%	12.23%	19.15%	20.74%	-0.48%	8.72%	25.21%	16.61%	19.49%	18.76%	18.26%
Net Nonoperating Expense Percent (NNEP)	1.03%	-0.18%	1.76%	-1.07%	13.31%	-2.62%	1.70%	-0.27%	2.82%	5.74%	-2.48%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	3.53%	-	-	-	2.55%
Cost of Revenue to Revenue	45.17%	46.01%	42.48%	42.93%	62.67%	47.08%	43.98%	46.72%	44.60%	43.55%	43.19%
SG&A Expenses to Revenue	9.17%	10.22%	10.10%	9.82%	9.16%	9.83%	11.04%	9.86%	9.29%	10.45%	11.32%
R&D to Revenue	6.49%	7.97%	6.96%	7.21%	7.38%	7.71%	6.59%	7.33%	6.34%	6.81%	5.90%
Operating Expenses to Revenue	28.51%	39.21%	33.09%	30.56%	37.19%	38.91%	36.45%	32.61%	31.27%	33.17%	34.32%
Earnings before Interest and Taxes (EBIT)	269	158	247	275	7.30	138	189	220	244	225	254
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	378	265	333	356	89	213	278	294	317	300	328
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.54	3.22	3.61	3.75	3.85	3.39	3.76	3.78	3.50	3.66	3.45
Price to Tangible Book Value (P/TBV)	64.21	43.78	33.59	24.82	21.12	20.07	33.97	22.87	17.82	22.29	29.57
Price to Revenue (P/Rev)	3.38	3.23	4.12	4.90	4.93	4.22	4.41	4.62	4.35	4.66	4.08
Price to Earnings (P/E)	11.70	12.08	18.57	26.42	41.17	37.28	33.98	39.23	24.70	23.78	22.15
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	8.55%	8.28%	5.38%	3.78%	2.43%	2.68%	2.94%	2.55%	4.05%	4.21%	4.52%
Enterprise Value to Invested Capital (EV/IC)	3.32	3.45	3.42	3.63	3.81	3.33	3.43	3.57	3.44	3.60	3.21
Enterprise Value to Revenue (EV/Rev)	3.47	3.82	4.21	4.97	4.95	4.25	4.57	4.72	4.37	4.69	4.21
Enterprise Value to EBITDA (EV/EBITDA)	7.61	8.84	11.20	15.14	19.20	17.28	19.40	21.40	15.84	15.91	13.73
Enterprise Value to EBIT (EV/EBIT)	9.33	11.11	14.80	21.25	29.10	25.66	29.77	33.71	22.05	21.50	18.02
Enterprise Value to NOPAT (EV/NOPAT)	11.49	13.81	18.14	25.94	41.14	37.95	36.63	41.38	25.00	23.45	23.02
Enterprise Value to Operating Cash Flow (EV/OCF)	7.49	8.73	10.36	21.02	20.81	16.28	17.83	16.93	14.82	14.70	13.55
Enterprise Value to Free Cash Flow (EV/FCFF)	7.87	9.00	10.87	24.91	28.76	24.70	26.12	23.91	19.72	27.19	22.81
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.57	0.58	0.56	0.54	0.55	0.56	0.55	0.53	0.52	0.50	0.53
Long-Term Debt to Equity	0.57	0.58	0.55	0.53	0.54	0.51	0.55	0.52	0.51	0.49	0.52
Financial Leverage	0.31	0.26	0.22	0.10	0.05	0.06	0.11	0.06	0.02	0.02	0.12
Leverage Ratio	2.02	1.98	1.93	1.88	1.84	1.84	1.82	1.79	1.80	1.80	1.82
Compound Leverage Factor	1.87	1.79	1.87	1.91	3.04	1.94	1.84	1.72	1.77	1.78	1.78
Debt to Total Capital	36.24%	36.82%	35.84%	34.89%	35.38%	36.09%	35.62%	34.62%	34.05%	33.18%	34.71%
Short-Term Debt to Total Capital	0.10%	0.19%	0.26%	0.32%	0.40%	3.66%	0.52%	0.50%	0.50%	0.49%	0.64%
Long-Term Debt to Total Capital	36.15%	36.62%	35.58%	34.57%	34.98%	32.44%	35.10%	34.12%	33.55%	32.69%	34.07%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	63.76%	63.18%	64.16%	65.11%	64.62%	63.91%	64.38%	65.38%	65.95%	66.82%	65.29%
Debt to EBITDA	1.19	1.35	1.70	2.13	2.72	2.86	2.75	2.94	2.32	2.14	2.05
Net Debt to EBITDA	0.20	1.35	0.24	0.19	0.07	0.11	0.69	0.44	0.11	0.10	0.42
Long-Term Debt to EBITDA	1.19	1.35	1.68	2.11	2.69	2.57	2.71	2.90	2.29	2.11	2.01
Debt to NOPAT	1.80	2.11	2.75	3.66	5.84	6.29	5.20	5.68	3.66	3.16	3.44
Net Debt to NOPAT	0.29	2.11	0.39	0.33	0.15	0.25	1.30	0.85	0.17	0.15	0.70
Long-Term Debt to NOPAT	1.79	2.10	2.73	3.62	5.77	5.65	5.12	5.60	3.61	3.12	3.37
Altman Z-Score	3.68	3.48	3.86	4.11	4.04	3.67	4.04	4.16	4.00	4.12	3.89
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.91	4.12	4.21	4.41	4.42	3.47	3.89	3.97	3.99	3.69	3.49
Quick Ratio	3.08	0.66	3.26	3.45	3.52	2.77	2.90	2.96	3.06	2.83	2.60
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	970	835	898	245	205	324	455	499	384	75	193
Operating Cash Flow to CapEx	1,286.77%	533.54%	870.79%	642.68%	911.78%	492.76%	578.95%	1,044.29%	1,197.05%	1,211.22%	599.05%
Free Cash Flow to Firm to Interest Expense	42.72	34.64	31.95	9.00	7.39	11.55	17.48	15.44	12.03	2.34	6.34
Operating Cash Flow to Interest Expense	14.57	7.00	9.02	7.58	12.01	9.21	8.46	9.05	12.72	11.50	6.21
Operating Cash Flow Less CapEx to Interest Expense	13.44	5.68	7.98	6.40	10.70	7.34	7.00	8.19	11.66	10.55	5.17
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.58	0.54	0.48	0.43	0.43	0.44	0.45	0.44	0.44	0.44	0.47
Accounts Receivable Turnover	6.35	6.23	5.42	5.31	5.81	6.48	5.90	5.82	6.06	6.57	6.20
Inventory Turnover	3.53	3.32	3.07	2.95	3.10	3.16	2.97	2.97	2.70	2.78	2.68
Fixed Asset Turnover	10.04	9.30	8.52	8.07	8.21	8.07	7.77	7.75	7.80	7.64	7.59
Accounts Payable Turnover	9.01	9.02	9.09	8.68	9.83	10.51	10.10	10.17	9.50	9.51	8.55
Days Sales Outstanding (DSO)	57.48	58.56	67.40	68.70	62.80	56.29	61.83	62.72	60.20	55.52	58.84
Days Inventory Outstanding (DIO)	103.29	110.05	118.83	123.85	117.89	115.65	122.84	123.03	135.14	131.36	136.07
Days Payable Outstanding (DPO)	40.49	40.46	40.14	42.06	37.13	34.74	36.12	35.88	38.42	38.37	42.68
Cash Conversion Cycle (CCC)	120.28	128.15	146.09	150.48	143.57	137.20	148.54	149.86	156.91	148.50	152.24
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	5,464	5,378	5,496	5,560	5,254	5,136	5,297	5,230	5,068	5,247	5,290
Invested Capital Turnover	0.90	0.85	0.76	0.73	0.75	0.77	0.74	0.73	0.77	0.78	0.76
Increase / (Decrease) in Invested Capital	-727	-718	-692	-32	-209	-242	-199	-330	-187	111	-6.70
Enterprise Value (EV)	18,154	18,565	18,794	20,156	20,000	17,110	18,144	18,685	17,445	18,889	16,992
Market Capitalization	17,689	15,723	18,391	19,897	19,928	16,999	17,501	18,300	17,328	18,772	16,476
Book Value per Share	$20.04	$19.53	$20.72	$21.50	$21.05	$20.48	$19.50	$20.64	$21.21	$22.09	$21.03
Tangible Book Value per Share	$1.10	$1.44	$2.23	$3.25	$3.83	$3.46	$2.16	$3.41	$4.17	$3.63	$2.45
Total Capital	7,839	7,718	7,937	8,142	8,019	7,850	7,229	7,410	7,507	7,677	7,310
Total Debt	2,841	2,841	2,845	2,841	2,837	2,834	2,575	2,565	2,556	2,547	2,537
Total Long-Term Debt	2,834	2,826	2,824	2,815	2,806	2,547	2,537	2,528	2,519	2,509	2,490
Net Debt	466	2,841	403	259	72	111	643	385	117	117	517
Capital Expenditures (CapEx)	26	32	29	32	37	53	38	28	34	30	32
Debt-free, Cash-free Net Working Capital (DFCFNWC)	540	2,939	644	700	625	542	701	692	593	490	565
Debt-free Net Working Capital (DFNWC)	2,916	2,939	3,086	3,283	3,390	3,264	2,633	2,872	3,032	2,824	2,538
Net Working Capital (NWC)	2,908	2,924	3,065	3,256	3,358	2,977	2,595	2,834	2,995	2,786	2,491
Net Nonoperating Expense (NNE)	14	-2.15	18	-5.63	36	-8.15	8.89	-0.88	2.67	6.77	-14
Net Nonoperating Obligations (NNO)	466	502	403	259	72	119	643	385	117	117	517
Total Depreciation and Amortization (D&A)	109	107	86	81	81	76	88	74	72	75	74
Debt-free, Cash-free Net Working Capital to Revenue	10.34%	60.44%	14.43%	17.27%	15.47%	13.44%	17.65%	17.46%	14.87%	12.16%	14.00%
Debt-free Net Working Capital to Revenue	55.79%	60.44%	69.09%	80.92%	83.94%	80.99%	66.32%	72.50%	76.04%	70.06%	62.84%
Net Working Capital to Revenue	55.65%	60.14%	68.63%	80.27%	83.15%	73.87%	65.38%	71.56%	75.10%	69.13%	61.68%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.91	$0.49	$0.76	$0.88	($0.16)	$0.37	$1.03	$0.72	$0.83	$0.77	$0.87
Adjusted Weighted Average Basic Shares Outstanding	250.76M	251.53M	247.32M	247.73M	246.91M	246.77M	238.63M	235.89M	234.60M	235.72M	230.28M
Adjusted Diluted Earnings per Share	$0.90	$0.48	$0.75	$0.87	($0.16)	$0.37	$1.03	$0.72	$0.82	$0.75	$0.87
Adjusted Weighted Average Diluted Shares Outstanding	253.09M	253.85M	249.28M	249.79M	246.91M	248.83M	240.21M	237.56M	236.47M	237.55M	232.11M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	249.65M	245.83M	246.55M	246.12M	244.94M	240.00M	234.73M	233.38M	232.27M	226.94M	224.39M
Normalized Net Operating Profit after Tax (NOPAT)	243	118	207	214	33	87	158	175	202	190	190
Normalized NOPAT Margin	24.27%	12.36%	19.23%	20.87%	3.40%	9.18%	15.55%	17.16%	20.02%	19.28%	18.57%
Pre Tax Income Margin	24.77%	15.05%	22.26%	27.21%	1.23%	15.40%	18.88%	20.78%	23.80%	22.43%	24.22%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	11.84	6.57	8.78	10.11	0.26	4.90	7.28	6.81	7.66	7.06	8.32
NOPAT to Interest Expense	10.69	4.84	7.32	7.83	-0.17	2.93	9.82	5.23	6.18	5.81	6.12
EBIT Less CapEx to Interest Expense	10.70	5.26	7.74	8.93	-1.05	3.04	5.82	5.94	6.59	6.11	7.29
NOPAT Less CapEx to Interest Expense	9.56	3.52	6.28	6.65	-1.49	1.07	8.36	4.37	5.12	4.86	5.08
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	24.28%	41.64%	47.98%	43.17%	90.62%	104.12%	204.15%	214.71%	140.84%	105.78%	90.81%

Frequently Asked Questions About Hologic's Financials

When does Hologic's fiscal year end?

According to the most recent income statement we have on file, Hologic's financial year ends in September. Their financial year 2024 ended on September 28, 2024.

How has Hologic's net income changed over the last 9 years?

Hologic's net income appears to be on an upward trend, with a most recent value of $789.50 million in 2024, rising from $131.60 million in 2015. The previous period was $456 million in 2023.

What is Hologic's operating income?

Hologic's total operating income in 2024 was $882.60 million, based on the following breakdown:

Total Gross Profit: $2.23 billion
Total Operating Expenses: $1.35 billion

How has Hologic revenue changed over the last 9 years?

Over the last 9 years, Hologic's total revenue changed from $2.71 billion in 2015 to $4.03 billion in 2024, a change of 49.0%.

How much debt does Hologic have?

Hologic's total liabilities were at $4.03 billion at the end of 2024, a 2.3% decrease from 2023, and a 27.6% decrease since 2015.

How much cash does Hologic have?

In the past 9 years, Hologic's cash and equivalents has ranged from $0.00 in 2021 to $2.72 billion in 2023, and is currently $2.16 billion as of their latest financial filing in 2024.

How has Hologic's book value per share changed over the last 9 years?

Over the last 9 years, Hologic's book value per share changed from 7.38 in 2015 to 22.09 in 2024, a change of 199.3%.

Related Companies

This page (NASDAQ:HOLX) was last updated on 4/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hologic (HOLX) Financials

Frequently Asked Questions About Hologic's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hologic (HOLX) Financials

Annual Income Statements for Hologic

Quarterly Income Statements for Hologic

Annual Cash Flow Statements for Hologic

Quarterly Cash Flow Statements for Hologic

Annual Balance Sheets for Hologic

Quarterly Balance Sheets for Hologic

Annual Metrics and Ratios for Hologic

Quarterly Metrics and Ratios for Hologic

Frequently Asked Questions About Hologic's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools